DSIP (5mg)

DSIP (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (nine amino acids) originally isolated from the central nervous system. Known primarily for its capacity to regulate sleep cycles, current research suggests DSIP is a multifaceted neuropeptide that also modulates stress tolerance, pain signaling, and endocrine function. (1)(2)

First characterized in the mid-1970s, DSIP has remained a focal point of neuroscientific interest due to its potential to mitigate withdrawal symptoms and optimize physiological homeostasis. (3)

Mechanisms of Action

DSIP directly engages with the central nervous system to alter sleep architecture and stress responses. While researchers are actively mapping its exact pathways, molecular studies demonstrate that DSIP interacts with several critical receptor pathways:

• GABA and NMDA Receptors: Studies indicate DSIP enhances the calming actions of gamma-aminobutyric acid (GABA) receptors while dampening the stimulatory effects of N-methyl-D-aspartate (NMDA) receptors. This joint action significantly reduces overall brain hyper-excitation. (4)(5)

• Opioid Receptors: Evidence suggests DSIP indirectly influences central opioid signaling, which researchers believe underpins its ability to alleviate withdrawal symptoms and alter pain perception. (6)(7)

• Alpha 1-Adrenergic Receptors: Located prominently in the pineal gland, modulation of these receptors by DSIP suggests a secondary role in regulating cellular stress tolerance and systemic circadian rhythms. (8)

Chemical Makeup

• Molecular Formula: $C_{35}H_{48}N_{10}O_{15}$

• Molecular Weight: 848.82 g/mol

• Synonyms: DSIP nonapeptide, emideltide

Research and Clinical Studies

1. Optimization of Sleep Cycles

Data highlights DSIP’s profound impact on deep sleep induction without disrupting standard sleep architecture:

• Slow-Wave Sleep (SWS) Induction: In animal models, DSIP administration led to an immediate, statistically significant increase in total sleep and slow-wave sleep (deep sleep) within the first hour, sustaining the effect for up to 7 hours. (9)

• Sleep Efficiency: Clinical data revealed an immediate increase in baseline sleep pressure, resulting in a 59% increase in total sleep within two hours of administration, driven primarily by a shortened sleep onset timeline. (10)

2. Endocrine & Growth Hormone Regulation

DSIP acts on the hypothalamus to orchestrate critical hormonal releases typically synchronized with deep sleep phases:

• Luteinizing Hormone (LH): Experimental models showed sharply elevated LH levels within 30 minutes of introduction, hinting at a regulatory role in upstream testosterone production pathways. (11)

• Growth Hormone (GH) Secretion: Further research shows DSIP stimulates systemic growth hormone release through localized hypothalamic and pituitary actions, mirroring the physiological growth spikes seen during slow-wave sleep. (12)

3. Mitigating the Stress Response

DSIP functions as a powerful molecular buffer against external stressors. In models exposed to acute stress, pre-treatment with DSIP directly stabilized key stress markers: (13)

• Corticosterone Suppression: Markedly reduced systemic corticosterone levels following stress exposure.

• Beta-Endorphin Regulation: Modulated opioidergic responses to build localized adaptation and cellular resilience against environmental anxiety.

4. Antioxidant Effects & Cellular Longevity

In long-term physiological studies, DSIP demonstrated prominent geroprotective and systemic protective qualities:

• Lifespan & Mass Regulation: Models showed an improved lifespan of 24% and a notable 2.5-fold decrease in the occurrence of spontaneous malignancies compared to controls. (14)

• Oxidative Stress Reduction: DSIP directly inhibits malonic dialdehyde (a damaging byproduct of lipid peroxidation) while actively stimulating endogenous antioxidant defense systems including superoxide dismutase, catalase, and ceruloplasmin. (15)

Product Notice: DSIP is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering.

References:

1. National Center for Biotechnology Information. “PubChem Compound Summary for CID 3623358, Emideltide; delta Sleep-Inducing Peptide.” PubChem,

2. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): an update. Peptides. 1986 Nov-Dec;7(6):1165-87.

3. Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006 Apr;97(2):303-9.

4. Grigor’ev VV, et al. Effects of delta sleep-inducing peptide on pre- and postsynaptic glutamate and postsynaptic GABA receptors… Bull Exp Biol Med. 2006 Aug;142(2):186-8.

5. Sudakov KV, Umriukhin PE, Rayevsky KS. Delta-sleep inducing peptide and neuronal activity after glutamate microiontophoresis: the role of NMDA-receptors. Pathophysiology. 2004 Oct;11(2):81-86.

6. Nakamura A, et al. Delta-sleep-inducing peptide (DSIP) stimulates the release of immunoreactive Met-enkephalin… Brain Res. 1989 Feb 27;481(1):165-8.

7. Dick P, Grandjean ME, Tissot R. Successful treatment of withdrawal symptoms with delta sleep-inducing peptide… Neuropsychobiology. 1983;10(4):205-8.

8. Graf MV, Schoenenberger GA. Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity… J Neurochem. 1987 Apr;48(4):1252-7.

9. Susić V, Masirević G, Totić S. The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat. Brain Res. 1987 Jun 30;414(2):262-70.

10. Schneider-Helmert D, et al. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):341-5.

11. Iyer KS, McCann SM. Delta sleep inducing peptide (DSIP) stimulates the release of LH but not FSH… Brain Res Bull. 1987 Nov;19(5):535-8.

12. Iyer KS, McCann SM. Delta sleep-inducing peptide (DSIP) stimulates growth hormone (GH) release in the rat… Peptides. 1987 Jan-Feb;8(1):45-8.

13. Sudakov KV, et al. Delta-sleep-inducing peptide sequels in the mechanisms of resistance to emotional stress. Ann N Y Acad Sci. 1995 Dec 29;771:240-51.

14. Popovich IG, et al. Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span… Mech Ageing Dev. 2003 Jun;124(6). Bondarenko TI, Maĭboroda EA, Mikhaleva II, Prudchenko IA. [Mechanism of delta-sleep inducing peptide geroprotective activity]. Adv Gerontol. 2011;24(1):80-92.

About the Reviewer

Dr. Marinov (MD, PhD) is a dedicated researcher and chief assistant professor in Preventive Medicine & Public Health. Specializing in peptide therapies and evidence-based clinical science, Dr. Marinov’s extensive peer-reviewed contributions ensure the highest standards of analytical clarity and technical accuracy.